Search Results - "Bell, David S.H."

Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus by Patil, Harshal R., MD, Al Badarin, Firas J., MD, Al Shami, Hamza A., MD, Bhatti, Salman K., MD, Lavie, Carl J., MD, Bell, David S.H., MB, O'Keefe, James H., MD

“…Patients with type 2 diabetes mellitus (DM) have a very high risk for major adverse cardiovascular (CV) events. Previous studies have shown that traditional…”
Get full text

Effect of Rosiglitazone Versus Insulin on the Pancreatic β-Cell Function of Subjects With Type 2 Diabetes by OVALLE, Fernando, BELL, David S. H

“…Effect of Rosiglitazone Versus Insulin on the Pancreatic β-Cell Function of Subjects With Type 2 Diabetes Fernando Ovalle , MD, FACE and David S.H. Bell , MB,…”
Get full text

Anemia and the role of erythropoietin in diabetes by McGill, Janet B., Bell, David S.H.

“…Anemia is more common in patients with diabetes than without diabetes, and the problem is magnified in patients with renal impairment. Diabetic patients with…”
Get full text

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy by Albright, Eric S, Desmond, Renee, Bell, David S H

Get full text

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE by Jellinger, Paul S, Handelsman, Yehuda, Rosenblit, Paul D, Bloomgarden, Zachary T, Fonseca, Vivian A, Garber, Alan J, Grunberger, George, Guerin, Chris K, Bell, David S H, Mechanick, Jeffrey I, Pessah-Pollack, Rachel, Wyne, Kathleen, Smith, Donald, Brinton, Eliot A, Fazio, Sergio, Davidson, Michael

“…The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of…”
Get more information

Heart failure: The frequent, forgotten, and often fatal complication of diabetes by BELL, David S. H

“…There is a high frequency of heart failure (HF) accompanied by an increased mortality risk for patients with diabetes. The poor prognosis of these patients has…”
Get full text

Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetabolism) Is a Cardiovascular Risk Factor by O’Keefe, James H., MD, Bell, David S.H., MB

“…Epidemiologic data indicate that a postprandial state characterized by abnormally increased levels of glucose and lipids (also referred to as postprandial…”
Get full text

Diabetogenic effects of cardioprotective drugs by Bell, David S.H., Goncalves, Edison

“…Drugs that protect against cardiovascular events in the patient with diabetes may also positively or negatively affect glycaemic control in the patient with…”
Get full text

Statin Neuropathy Masquerading as Diabetic Autoimmune Polyneuropathy by Vaughan, Tom Brooks, Bell, David S.H

Get full text

Diabetic cardiomyopathy by Bell, David S H

“…Bell comments on diabetic cardiomyopathy, arguing that its prevalence in type 2 diabetic patients is higher than was previously believed, and that diabetic…”
Get full text

Human Medicines Inappropriately Used in Animals Come at a Much Lower Cost by Bell, David S.H

Get full text

Type 2 diabetes mellitus: what is the optimal treatment regimen? by Bell, David S H

“…Treatment options for type 2 diabetes mellitus currently consist of insulin sensitizers, alpha-glucosidase inhibitors, secretagogues, and insulin. However, the…”
Get more information

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus by O'Keefe, James H., MD, Abuannadi, Mohammad, MD, Lavie, Carl J., MD, Bell, David S.H., MD

“…Type 2 diabetes mellitus (DM) is a major cardiovascular (CV) risk factor and, as such, is considered a coronary artery disease risk equivalent. Although…”
Get full text

Do sulfonylurea drugs increase the risk of cardiac events? by Bell, David S H

“…Bell comments on Simpson's study of Sulfonylureas drugs and cardiac events. The findings of Simpson and colleagues add to the existing evidence that suggests…”
Get full text

Treatment of diabetic hypertension by Bell, David S.H

“…Insulin resistance and hyperglycaemia combine to make hypertension more prevalent in the type 2 diabetic patient. Blood pressure goals below those for the…”
Get full text

Beta-cell rejuvenation with thiazolidinediones by Bell, David S H

“…Type 2 diabetes mellitus manifests in an insulin-resistant individual when pancreatic beta-cells are unable to produce sufficient insulin to overcome insulin…”
Get more information

Prevalence and Risk Factors of Microalbuminuria in a Cohort of African-American Women With Gestational Diabetes by GO, Rodney C. P, DESMOND, Renee, ROSEMAN, Jeffrey M, BELL, David S. H, VANICHANAN, Chotip, ACTON, Ronald T

“…Prevalence and Risk Factors of Microalbuminuria in a Cohort of African-American Women With Gestational Diabetes Rodney C.P. Go , PHD 1 , Renee Desmond , PHD 2…”
Get full text

Body Weight Changes with β-Blocker Use: Results from GEMINI by Messerli, Franz H., MD, Bell, David S.H., MB, Fonseca, Vivian, MD, Katholi, Richard E., MD, McGill, Janet B., MD, Phillips, Robert A., MD, PhD, Raskin, Philip, MD, Wright, Jackson T., MD, PhD, Bangalore, Sripal, MD, Holdbrook, Fred K., PhD, Lukas, Mary Ann, MD, Anderson, Karen M., PhD, Bakris, George L., MD

“…Abstract Purpose Patients with type 2 diabetes are commonly overweight, which can contribute to poor cardiovascular outcomes. β-blockers may promote weight…”
Get full text

Advantages of a third-generation β-blocker in patients with diabetes mellitus by Bell, David S.H

“…β-Blocker use improves outcomes even more for the patient with diabetes mellitus than for the patient without diabetes with a history of acute myocardial…”
Get full text

Heart Failure: A Serious and Common Comorbidity of Diabetes by Bell, David S.H.

“…Heart Failure: A Serious and Common Comorbidity of Diabetes David S.H. Bell , MB, FACE Abstract In Brief Because of the cardiotoxic triad (diabetic…”
Get full text